The “Lay Line” is the straight line tracing the course following which a boat can fetch an upwind mark (the shortest track to reach the target).
The location of lay-lines is affected not only by wind direction shifts, but by changes in wind velocity as well. Watching for wind shifts means to take advantage of, and try to evaluate which side of the course is favorable, understanding the upwind impact. When we are exploring, we lay line to ensure our continuous guideline back to the surface, but also to allow us to survey and map the new passage. When we lay line, we do not necessarily lay the line for the easiest navigation. Each run of line is made to try to go as long as possible in a straight line.
Lay Line Genomics's mission is to discover and develop innovative small molecules and biopharmaceuticals for Alzheimer’s and other neurological diseases.
With its powerful technology platform the company is able to identify and develop its pipeline of therapeutic and diagnostic leads. The product portfolio of Lay Line Genomics is composed of seven pre-clinical candidates, two of them have recently been licensed out to a pharmaceutical company partner for further development.
Lay Line Genomics Spa is a spin-off of the International School for Advanced Study (SISSA) of Trieste, Italy.
